JACC: Basic to Translational Science (Apr 2017)

Ticagrelor Removal From Human Blood

  • George O. Angheloiu, MD,
  • Gabriel B. Gugiu, PhD,
  • Cristian Ruse, PhD,
  • Rishikesh Pandey, PhD,
  • Ramachandra R. Dasari, PhD,
  • Carl Whatling, PhD

Journal volume & issue
Vol. 2, no. 2
pp. 135 – 145

Abstract

Read online

Summary: The authors devised an efficient method for ticagrelor removal from blood using sorbent hemadsorption. Ticagrelor removal was measured in 2 sets of in vitro experiments. The first set was a first-pass experiment using bovine serum albumin (BSA) solution pre-incubated with ticagrelor, whereas the second set, performed in a recirculating manner, used human blood mixed with ticagrelor. Removal of ticagrelor from BSA solution reached values >99%. The peak removal rate was 99% and 94% from whole blood and 99.99% and 90% from plasma during 10 h and 3 to 4 h of recirculating experiments, respectively. In conclusion, hemadsorption robustly removes ticagrelor from BSA solution and human blood samples. Key Words: concentration, drug, P2Y12, platelet, removal, sorbent, ticagrelor